Bath & Body Works Earnings Prompt Guidance Cut
Bath & Body Works earnings showed softer Q3 sales and a trimmed 2025 outlook, pushing traders to weigh weaker sales and the $400 million buyback plan.
KEY TAKEAWAYS
- Reported Q3 net sales of $1,594 million, down 1.0%.
- Cut 2025 sales outlook to a low single-digit decline, with Q4 seen down high single digits.
- Announced $250 million in cost savings and included $400 million of share repurchases in guidance.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
Bath & Body Works (BBWI) reported third-quarter results and on Nov. 20, 2025 outlined a strategic "Consumer First Formula," lowered its 2025 sales outlook, and announced targeted cost savings and buybacks that narrow near-term revenue and profit visibility for traders and investors.
Third-Quarter Results and Outlook
Bath & Body Works said in a press release that third-quarter 2025 net sales were $1,594 million, down 1.0% year-over-year, and diluted earnings per share were $0.37 (adjusted $0.35). Operating income declined to $161 million from $218 million a year earlier. The company said it is acting swiftly to position the business for sustainable, long-term growth.
Management revised full-year 2025 net-sales guidance to a low single-digit decline from a prior range of 1.5%–2.7% growth and expects fourth-quarter net sales to fall in the high single digits. It set full-year EPS guidance at at least $2.83 (adjusted at least $2.87).
Direct sales in the U.S. and Canada were $299 million, down 7.0% year-over-year, while international sales rose 6.1% to $73 million. The company ended the quarter with 1,934 stores in those markets.
Interest expense fell to $68 million from $77 million a year earlier, and cash and cash equivalents stood at $236 million at quarter-end.
Strategic Reset and Capital Actions
Management introduced the "Consumer First Formula," focusing on product innovation, brand reignition, marketplace expansion, and faster operations to stabilize performance.
The company announced targeted cost savings of $250 million over two years and included $400 million of share repurchases in its guidance. It projects full-year free cash flow at approximately $650 million. The outlook assumes continued macro consumer pressures and weak sentiment as the company implements the program.
Bath & Body Works reported no regulatory filings, approvals, or merger-and-acquisition activity tied to the quarter or the strategic transformation.
The trimmed outlook and linked cost-savings and buyback program narrow near-term revenue and profit visibility, placing a premium on execution as the company works to restore growth.
